Search

Introduction Patients with generalised anxiety disorder (GAD) have concerns and needs about their health and the healthcare they receive. Patient decision aids (PtDAs) are tools that assist patients in making health decisions, when there is uncertainty about treatment choice, incorporating their personal preferences and values about the available treatment options. PtDAs can improve shared decision-making and lead to better treatment outcomes. The aim of this study is to evaluate the effectiveness of a web-based PtDA for patients with GAD in primary care (PC).Methods and analysis The general study design is comprised of two stages: (1) development of a web-based PtDA for patients with GAD, derived from an evidence-based Clinical Practice Guideline and (2) assessment of the effectiveness of the PtDA in a randomised controlled trial (RCT) design, in PC centres in Tenerife (Spain). This RCT will be carried out with 124 patients with GAD, comparing the PtDA to a fact sheet with general information on mental health. Patients will review the PtDA in one session accompanied by a researcher. Post-intervention measures will be administered immediately after the intervention and at 3-month follow-up. The primary outcome will be decisional conflict. Secondary outcomes will include knowledge about GAD and its treatment, treatment preference, concordance between treatment preference and choice, and decision quality (knowledge ≥60% and concordant decision).Ethics and dissemination The project received ethics approval from the local committee at Nuestra Señora de la Candelaria (HUNSC) University Hospital in Santa Cruz de Tenerife (code: CHUNSC_2019_58). Informed consent will be obtained from each participant before randomisation. Results from the trial will be submitted for publication in international peer-reviewed scientific journals and will be disseminated through workshops and local and international conferences.Trial registration number NCT04364958.

PurposeThe aim of this study was to translate, culturally adapt, and evaluate the psychometric properties of the Spanish Long-Term Quality of Life (LTQL) questionnaire.MethodsThe LTQL was initially translated into Spanish and cross-culturally adapted based on established guidelines. The Spanish LTQL was administered to patients with breast cancer who had completed their initial treatment 5 years earlier, along with other self-report measures: Quality of Life in Adult Cancer Survivors (QLACS), Hospital Anxiety and Depression Scale (HADS) and EORT-QLQ-BR23. Reliability was evaluated using internal consistency and test-retest. Convergent and known-groups validity were examined. Structural validity as determined by confirmatory factor analysis (CFA) and Rasch analyses was used to assess the unidimensionality and item-functioning of the LTQL domains.ResultsCronbach’s alpha were above 0.7 in all domains. Test-retest coefficients were between 0.72 to 0.96 for LTQL domains. LTQL total score was correlated with others total scores of other measures: QLACS (r=-0.39), HADS depression (r=-0.57), HADS anxiety (-0.45) and EORTC-QLQ-BR23 (r=-0.50). CFA provided satisfactory fit indices, with RMSEA value of 0.077 and TLI and CFI values of 0.901 and 0.909, respectively. All factor loadings were higher than 0.40 and statistically significant (P

Objetivo: La exposición crónica a plaguicidas no persistentes se ha relacionado con diversas patologías crónicas; sin embargo, pocos estudios han evaluado la exposición a plaguicidas no persistentes en población española. Métodos: En 2007 se determinó la presencia de 24 plaguicidas mediante cromatografía de gases/espectometría de masas en 363 muestras de suero de adultos no laboralmente expuestos de Tenerife. Resultados: El 99,45% presentaron residuos (6 ± 2 plaguicidas/muestra). Los plaguicidas más frecuentes fueron piretroides (96,1%), organofosforados (93,9%) y organoclorados (92,3%). En el 81% de los sujetos se detectaron bifentrina y malatión, considerados neurotóxicos, y en el 50% hexaclorobenceno, DDT y buprofezina. El malatión, un «obesógeno ambiental», se detectó en el 82%, y plaguicidas considerados «disruptores endocrinos» en el 97,2% de las muestras. Conclusiones: Existe una exposición inadvertida a plaguicidas no persistentes que puede afectar a la salud de nuestra población, por lo que se hace necesario incluirlos en los estudios de monitorización.